Original title: Damo: Sheng Shenwei Pharmaceutical (02877) Target Price to 6.3 Yuan Rating “Synchronize with Big Market” Source: Zhitong Financial Network

The Zhitong Finance App learned that Morgan Stanley published a report raising the target price of Shenwei Pharmaceutical (02877) from 5.9 yuan to 6.3 yuan, which is equivalent to predicting next year's price-earnings ratio 9 times, maintaining a “in sync with the market” rating.

According to the report, based on higher sales for the third quarter of this year, Shenwei Pharmaceutical raised its profit forecast by 6% to 7% for 2020 to 2022, to 0.59, 0.67 and 0.71 yuan, respectively, based on higher sales expectations for the third quarter of this year, especially in the injection and traditional Chinese medicine formula business.